Quest Diagnostics Incorporated (DGX) - Total Assets

Latest as of December 2025: $16.23 Billion USD

Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) holds total assets worth $16.23 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Quest Diagnostics Incorporated's book value for net asset value and shareholders' equity analysis.

Quest Diagnostics Incorporated - Total Assets Trend (1996–2025)

This chart illustrates how Quest Diagnostics Incorporated's total assets have evolved over time, based on quarterly financial data.

Quest Diagnostics Incorporated - Asset Composition Analysis

Current Asset Composition (December 2025)

Quest Diagnostics Incorporated's total assets of $16.23 Billion consist of 14.7% current assets and 85.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $420.00 Million 2.6%
Accounts Receivable $1.41 Billion 8.7%
Inventory $189.00 Million 1.2%
Property, Plant & Equipment $2.86 Billion 17.6%
Intangible Assets $1.64 Billion 10.1%
Goodwill $8.95 Billion 55.1%

Asset Composition Trend (1996–2025)

This chart illustrates how Quest Diagnostics Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Quest Diagnostics Incorporated (DGX) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Quest Diagnostics Incorporated's current assets represent 14.7% of total assets in 2025, a decrease from 36.6% in 1996.
  • Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, down from 3.0% in 1996.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 65.0% of total assets, an increase from 21.0% in 1996.
  • Asset Diversification: The largest asset category is goodwill at 55.1% of total assets.

Quest Diagnostics Incorporated Competitors by Total Assets

Key competitors of Quest Diagnostics Incorporated based on total assets are shown below.

Company Country Total Assets
Agilent Technologies Inc
NYSE:A
USA $12.73 Billion
Leveljump Healthcare Corp
V:JUMP
Canada CA$21.84 Million
StageZero Life Sciences Ltd
TO:SZLS
Canada CA$580.75K
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Healius Ltd
AU:HLS
Australia AU$1.77 Billion

Quest Diagnostics Incorporated - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.04 1.10 1.76
Quick Ratio 0.96 1.02 1.63
Cash Ratio 0.18 0.25 0.00
Working Capital $100.00 Million $223.00 Million $1.29 Billion

Quest Diagnostics Incorporated - Advanced Valuation Insights

This section examines the relationship between Quest Diagnostics Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.18
Latest Market Cap to Assets Ratio 1.29
Asset Growth Rate (YoY) 0.4%
Total Assets $16.23 Billion
Market Capitalization $20.85 Billion USD

Valuation Analysis

Above Book Valuation: The market values Quest Diagnostics Incorporated's assets above their book value (1.29x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Quest Diagnostics Incorporated's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Quest Diagnostics Incorporated (1996–2025)

The table below shows the annual total assets of Quest Diagnostics Incorporated from 1996 to 2025.

Year Total Assets Change
2025-12-31 $16.23 Billion +0.45%
2024-12-31 $16.15 Billion +15.20%
2023-12-31 $14.02 Billion +9.23%
2022-12-31 $12.84 Billion -5.69%
2021-12-31 $13.61 Billion -2.96%
2020-12-31 $14.03 Billion +9.21%
2019-12-31 $12.84 Billion +16.72%
2018-12-31 $11.00 Billion +4.76%
2017-12-31 $10.50 Billion +3.99%
2016-12-31 $10.10 Billion +1.39%
2015-12-31 $9.96 Billion +0.86%
2014-12-31 $9.88 Billion +10.38%
2013-12-31 $8.95 Billion -3.62%
2012-12-31 $9.28 Billion -0.32%
2011-12-31 $9.31 Billion +9.21%
2010-12-31 $8.53 Billion -0.42%
2009-12-31 $8.56 Billion +1.90%
2008-12-31 $8.40 Billion -1.89%
2007-12-31 $8.57 Billion +51.30%
2006-12-31 $5.66 Billion +6.70%
2005-12-31 $5.31 Billion +26.22%
2004-12-31 $4.20 Billion -2.27%
2003-12-31 $4.30 Billion +29.40%
2002-12-31 $3.32 Billion +13.43%
2001-12-31 $2.93 Billion +2.30%
2000-12-31 $2.86 Billion -0.49%
1999-12-31 $2.88 Billion +111.62%
1998-12-31 $1.36 Billion -2.91%
1997-12-31 $1.40 Billion +0.42%
1996-12-31 $1.40 Billion --

About Quest Diagnostics Incorporated

NYSE:DGX USA Diagnostics & Research
Market Cap
$20.85 Billion
Market Cap Rank
#1242 Global
#495 in USA
Share Price
$189.13
Change (1 day)
-0.90%
52-Week Range
$166.42 - $211.91
All Time High
$211.91
About

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics … Read more